Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities. | Front Oncol | 2022 | 36212415 | PubTator, text mining | PubMed |
| Bioinformatics and systems-biology analysis to determine the effects of Coronavirus disease 2019 on patients with allergic asthma. | Front Immunol | 2022 | 36211429 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the role of immune-related autophagy in spinal cord injury in rats. | Front Immunol | 2022 | 36211348 | PubTator, text mining | PubMed |
| Identification of Downregulated Exosome-Associated Gene ENPP1 as a Novel Lipid Metabolism and Immune-Associated Biomarker for Hepatocellular Carcinoma. | J Oncol | 2022 | 36199794 | PubTator, text mining | PubMed |
| Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. | Cell Discov | 2022 | 36198671 | PubTator, text mining | PubMed |
| Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma. | BMC Cancer | 2022 | 36195857 | PubTator, text mining | PubMed |
| CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. | Mol Cancer | 2022 | 36192735 | PubTator, text mining | PubMed |
| Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. | Nat Commun | 2022 | 36192482 | PubTator, text mining | PubMed |
| Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade. | Clin Cancer Res | 2022 | 36190538 | PubTator, text mining | PubMed |
| Identification and validation of key molecules associated with humoral immune modulation in Parkinson's disease based on bioinformatics. | Front Immunol | 2022 | 36189230 | PubTator, text mining | PubMed |
| Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressiveness. | Mater Today (Kidlington) | 2022 | 36188120 | PubTator, text mining | PubMed |
| Identification of Monocyte-Associated Genes Related to the Instability of Atherosclerosis Plaque. | Oxid Med Cell Longev | 2022 | 36187340 | PubTator, text mining | PubMed |
| Construction of a neural network diagnostic model and investigation of immune infiltration characteristics for Crohn's disease. | Front Genet | 2022 | 36186439 | PubTator, text mining | PubMed |
| Macrophage-extracellular matrix interactions: Perspectives for tissue engineered heart valve remodeling. | Front Cardiovasc Med | 2022 | 36176991 | PubTator, text mining | PubMed |
| Cuproptosis patterns and tumor immune infiltration characterization in colorectal cancer. | Front Genet | 2022 | 36176287 | PubTator, text mining | PubMed |
| Early IL-17A Prevention Rather Than Late IL-17A Neutralization Attenuates Toluene Diisocyanate-Induced Mixed Granulocytic Asthma. | Allergy Asthma Immunol Res | 2022 | 36174994 | PubTator, text mining | PubMed |
| Immunology of cell death in cancer and infection. | Genes Immun | 2022 | 36171397 | PubTator, text mining | PubMed |
| CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance. | Int J Inflam | 2022 | 36164329 | PubTator, text mining | PubMed |
| Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19. | Front Immunol | 2022 | 36159873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=45